Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management

Clinical Infectious Diseases

Volumn 35, Issue 8, 2002, Pages 909-920

  Anaissie, Elias ^a   Nucci, Marcio ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; NATAMYCIN; POSACONAZOLE; TERBINAFINE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FUNGEMIA; FUSARIUM; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN INFECTION; SKIN MANIFESTATION; SKIN METASTASIS;

FUSARIUM; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MYCOSES; SKIN DISEASES;

EID: 0037108390     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342328     Document Type: Article

References (139)

1. de Pauw BE, Meunier F. The challenge of invasive fungal infection. Chemotherapy 1999;45(Suppl 1):1-14.
2. Walsh TJ, Hiemenz JW, Anaissie E. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 1996;10:365-400.
3. Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001; 14: 643-58.
4. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994;7:479-504.
5. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood 1997;90: 999-1008.
6. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999;1:247-61.
7. Nucci M, Queiroz-Telles F, Trabasso P, et al. Epidemiologic study of systemic Fusarium infection in Brazil [abstract 1421]. In: Programs and abstracts of the 40th Interscience Symposium on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 2000:383.
8. Benjamin RP, Callaway L, Conant NF. Facial granuloma associated with fusarium infection, Arch Dermatol 1970;101:598-600.
9. Cho CT, Vats TS, Lowman IT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973;83:1028-31.
10. Abramowsky CR, Quinn D, Bradford WD, Conant NF. Systemic infection by fusarium in a burned child: the emergence of a saprophytic strain. J Pediatr 1974;84:561-4.
11. Gutmann L, Chou SM, Pore RS. Fusariosis, myasthenic syndrome, and aplastic anemia. Neurology 1975;25:922-6.
12. Collins MS, Rinaldi MG. Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia 1977;15:151-60.
13. Young NA, Kwon-Chung KJ, Kubota TT, Jennings AE, Fisher RI. Disseminated infection by Fusarium moniliforme during treatment for malignant lymphoma. J Clin Microbiol 1978;7:589-94.
14. Lieberman TW, Ferry AP, Bottone EJ. Fusarium solani endophthalmitis without primary corneal involvement. Am J Ophthalmol 1979;88: 764-7.
15. Young CN, Meyers AM. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia 1979;17:219-23.
16. van Dijk E, van den Berg WH, Landwehr AJ. Fusarium solani infection of a hypertensive leg ulcer in a diabetic. Mykosen 1980;23:603-6.
17. Mutton KJ, Lucas TJ, Harkness JL. Disseminated fusarium infection. Med J Aust 1980;2:624-5.
18. Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981;75:304-11.
19. Page JC, Friedlander G, Dockery GL. Postoperative fusarium osteomyelitis. J Foot Surg 1982;21:174-6.
20. Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983; 99:334-6.
21. Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM. Fusarium brain abscess: case report. J Neurosurg 1983;58:598-601.
22. Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J Rheumatol 1983;10:151-3.
23. Blazar BR, Hurd DD, Snover DC, Alexander JW, McGlave PB. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med 1984;77:645-51.
24. Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol 1985;21: 501-4.
25. Matsuda T, Matsumoto T. Disseminated hyalohyphomycosis in a leukemic patient. Arch Dermatol 1986;122:1171-5.
26. Valenstein P, Schell WA. Primary intranasal Fusarium infection: potential for confusion with rhinocerebral zygomycosis. Arch Pathol Lab Med 1986;110:751-4.
27. Anaissie E, Kantarjian H, Jones P, et al. Fusarium: a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986;57: 2141-5.
28. Attapattu MC, Anandakrishnan C. Extensive subcutaneous hyphomycosis caused by Fusarium oxysporum. J Med Vet Mycol 1986;24: 105-11.
29. June CH, Beatty PG, Shulman HM, Rinaldi MG. Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation. South Med J 1986;79:513-5.
30. Okuda C, Ito M, Sato Y, Oka K, Hotchi M. Disseminated cutaneous Fusarium infection with vascular invasion in a leukemic patient. J Med Vet Mycol 1987;25:177-86.
31. Veglia KS, Marks VJ. Fusarium as a pathogen: a case report of Fusarium sepsis and review of the literature. J Am Acad Dermatol 1987;16:260-3.
32. Uchiyama N, Shindo Y, Mikoshiba H, Saito H. Cutaneous infection caused by Fusarium solani and Fusarium oxysporum. J Dermatol 1987;14:471-5.
33. Rippon JW, Larson RA, Rosenthal DM, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 1988;101:105-11.
34. Summerbell RC, Richardson SE, Kane J. Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. J Clin Microbiol 1988;26:82-7.
35. Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusarium solani osteomyelitis with probable nosocomial spread. Am J Clin Pathol 1988;90:738-41.
36. Mowbray DN, Paller AS, Nelson PE, Kaplan RL. Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol 1988;27:698-701.
37. Richardson SE, Bannatyne RM, Summerbell RC, Milliken J, Gold R, Weitzman SS. Disseminated fusarial infection in the immunocompromised host. Rev Infect Dis 1988;10:1171-81.
38. Merz WG, Karp JE, Hoagland M, Jett-Goheen M, Junkins JM, Hood AE Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988;158:1046-55.
39. Venditti M, Micozzi A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988;10: 653-60.
40. Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988;67: 77-83.
41. Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1989;1:968.
42. Minor RL Jr, Pfaller MA, Gingrich RD, Burns LJ. Disseminated Fusarium infections in patients following bone marrow transplantation. Bone Marrow Transplant 1989;4:653-8.
43. el Ani AS. Disseminated infection caused by Fusarium solani in a patient with aplastic anemia. N Y State J Med 1990;90:609-10.
44. Viscoli C, Castagnola E, Moroni C, Garaventa A, Manno G, Savioli C. Infection with Fusarium species in two children with neuroblastoma. Eur J Clin Microbiol Infect Dis 1990;9:773-6.
45. Helm TN, Longworth DL, Hall GS, Bolwell BJ, Fernandez B, Tomecki KJ. Case report and review of resolved fusariosis. J Am Acad Dermatol 1990;23:393-8.
46. Nadler JP. Disseminated fusarial infection. Rev Infect Dis 1990;12: 162.
47. Barrios NJ, Kirkpatrick DV, Murciano A, Stine K, Van Dyke RB, Humbert JR. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Oncol 1990;12:319-24.
48. Lupinetti FM, Giller RH, Trigg ME. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg 1990;49:991-2.
49. Gradon JD, Lerman A, Lutwick LI. Septic arthritis due to Fusarium moniliforme. Rev Infect Dis 1990;12:716-7.
50. Schneller FR, Gulati SC, Cunningham IB, O’Reilly RJ, Schmitt HJ, Clarkson BD. Fusarium infections in patients with hematologic malignancies. Leuk Res 1990;14:961-6.
51. Gamis AS, Gudnason T, Giebink GS, Ramsay NK. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991;13:1077-88.
52. Robertson MJ, Socinski MA, Soiffer RJ, et al. Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 1991;8:143-5.
53. Agamanolis DP, Kalwinsky DK, Krill CE Jr, Dasu S, Halasa B, Galloway PG. Fusarium meningoencephalitis in a child with acute leukemia. Neuropediatrics 1991;22:110-2.
54. Viviani MA, Cofrancesco E, Boschetti C, Tortorano AM, Cortellaro M. Eradication of Fusarium infection in a leukopenic patient treated with liposomal amphotericin B. Mycoses 1991;34:255-6.
55. Lupinetti FM, Behrendt DM, Giller RH, Trigg ME, de Alarcon P. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation. J Thorac Cardiovasc Surg 1992;104:684-7.
56. Landau M, Srebrnik A, Wolf R, Bashi E, Brenner S. Systemic ketoconazole treatment for Fusarium leg ulcers. Int J Dermatol 1992;31: 511-2.
57. Neumeister B, Bartmann P, Gaedicke G, Marre R. A fatal infection due to Fusarium oxysporum in a child with Wilms’ tumour: case report and review of the literature. Mycoses 1992;35:115-9.
58. Brint JM, Flynn PM, Pearson TA, Pui CH. Disseminated fusariosis involving bone in an adolescent with leukemia. Pediatr Infect Dis J 1992;11:965-8.
59. Girmenia C, Arcese W, Micozzi A, Martino P, Bianco P, Morace G. Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clin Infect Dis 1992;14:1167.
60. Cofrancesco E, Boschetti C, Viviani MA, et al. Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient. Haematologica 1992;77:280-3.
61. Alvarez-Franco M, Reyes-Mugica M, Paller AS. Cutaneous Fusarium infection in an adolescent with acute leukemia. Pediatr Dermatol 1992;9:62-5.
62. Madhavan M, Ratnakar C, Veliath AJ, Kanungo R, Smile SR, Bhat S. Primary disseminated fusarial infection. Postgrad Med J 1992;68: 143-4.
63. Ammari LK, Puck JM, McGowan KL. Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis 1993;16:148-50.
64. Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 1992;106: 733-6.
65. Nucci M, Spector N, Lucena S, et al. Three cases of infection with Fusarium species in neutropenic patients. Eur J Clin Microbiol Infect Dis 1992;11:1160-2.
66. Castagnola E, Garaventa A, Conte M, Barretta A, Faggi E, Viscoli C. Survival after fungemia due to Fusarium moniliforme in a child with neuroblastoma. Eur J Clin Microbiol Infect Dis 1993;12:308-9.
67. Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis 1993;16:528-30.
68. Smith AG, Bustamante CI, Wood C. Disseminated cutaneous and vascular invasion by Fusarium moniliforme in a fatal case of acute lymphocytic leukemia. Mycopathologia 1993;122:15-20.
69. Caux F, Aractingi S, Baurmann H, et al. Fusarium solani cutaneous infection in a neutropenic patient. Dermatology 1993;186:232-5.
70. Mardiak J, Danisovicova A, Trupl J, Sloboda J, Jesenska Z, Krcmery V Jr. Three cases of fatal infection due to Fusarium solani in patients with cancer. Clin Infect Dis 1993;17:930-2.
71. Melcher GP, McGough DA, Fothergill AW, Norris C, Rinaldi MG. Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme. J Clin Microbiol 1993;31:1461-7.
72. Engelhard D, Eldor A, Polacheck I, et al. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma 1993;9:385-92.
73. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994; 28(Suppl 1):7-15.
74. Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis 1994;18:585-8.
75. Hennequin C, Benkerrou M, Gaillard JL, Blanche S, Fraitag S. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin Infect Dis 1994;18:490-1.
76. Rabodonirina M, Piens MA, Monier MF, Gueho E, Fiere D, Mojon M. Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis 1994;13:152-61.
77. Ellis ME, Clink H, Younge D, Hainau B. Successful combined surgical and medical treatment of fusarium infection after bone marrow transplantation. Scand J Infect Dis 1994;26:225-8.
78. Patel AS, Hemady RK, Rodrigues M, Rajagopalan S, Elman MJ. Endogenous Fusarium endophthalmitis in a patient with acute lymphocytic leukemia. Am J Ophthalmol 1994;117:363-8.
79. Bushelman SJ, Callen JP, Roth DN, Cohen LM. Disseminated Fusarium solani infection. J Am Acad Dermatol 1995;32:346-51.
80. Hansson C, Rosen K, Braide I. Fusarium infection with unusual skin lesions in a patient with acute lymphocytic leukemia. Dermatology 1995;191:333-5.
81. Freidank H. Hyalohyphomycoses due to Fusarium spp: two case reports and review of the literature. Mycoses 1995;38:69-74.
82. Raad I, Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 1995;20:709-11.
83. Mohammedi I, Gachot B, Grossin M, Marche C, Wolff M, Vachon F. Overwhelming myocarditis due to Fusarium oxysporum following bone marrow transplantation. Scand J Infect Dis 1995;27:643-4.
84. Leu HS, Lee AY, Kuo TT. Recurrence of Fusarium solani abscess formation in an otherwise healthy patient. Infection 1995;23:303-5.
85. Lopes JO, de Mello ES, Klock C. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukaemic patient. Mycoses 1995;38:281-4.
86. Velasco E, Martins CA, Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 1995;14:697-9.
87. Wolff MA, Ramphal R. Use of amphotericin B lipid complex for treatment of disseminated cutaneous fusarium infection in a neutropenic patient. Clin Infect Dis 1995;20:1568-9.
88. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med 1995;152:1379-81.
89. Myoken Y, Sugata T, Kyo T, Fujihara M. Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report. J Oral Pathol Med 1995;24:237-40.
90. Eljaschewitsch J, Sandfort J, Tintelnot K, Horbach I, Ruf B. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 1996; 39: 115-9.
91. Heinz T, Perfect J, Schell W, Ritter E, Ruff G, Serafin D. Soft-tissue fungal infections: surgical management of 12 immunocompromised patients. Plast Reconstr Surg 1996; 97:1391-9.
92. Patterson TS, Barton LL, Shehab ZM, Hutter JJ. Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection. Clin Pediatr (Phila) 1996; 35:257-60.
93. Krulder JW, Brimicombe RW, Wijermans PW, Gams W. Systemic Fusarium nygamai infection in a patient with lymphoblastic nonHodgkin’s lymphoma. Mycoses 1996; 39:121-3.
94. Rombaux P, Eloy P, Bertrand B, Delos M, Doyen C. Lethal disseminated Fusarium infection with sinus involvement in the immunocompromised host: case report and review of the literature. Rhinology 1996; 34:237-41.
95. Clancy CJ, Nguyen MH. Disseminated fusariosis [photo quiz]. Clin Infect Dis 1996; 23:963-1.
96. Antony SJ. Disseminated Fusarium infection in an immunocompromised host. Int J Dermatol 1996; 35:815-6.
97. Glasgow BJ, Engstrom RE Jr, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1996; 114: 873-7.
98. Gabriele P, Hutchins RK. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol 1996; 122:119-21.
99. Repiso T, Garcia-Patos V, Martin N, Creus M, Bastida P, Castells A. Disseminated fusariosis. Pediatr Dermatol 1996; 13:118-21.
100. Child FJ, Fuller LC, Higgins EM, du Vivier AW, Mufti GJ. Cutaneous presentation of Fusarium solani infection in a bone marrow transplant recipient. J R Soc Med 1996; 89:647-8.
101. Arrese JE, Pierard-Franchimont C, Pierard GE. Fatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient. Am J Dermatopathol 1996; 18:196-8.
102. Flynn JT, Meislich D, Kaiser BA, Polinsky MS, Baluarte HJ. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit Dial Int 1996; 16:52-7.
103. Bleggi-Torres LF, de Medeiros BC, Neto JZ, et al. Disseminated Fusarium sp. infection affecting the brain of a child after bone marrow transplantation. Bone Marrow Transplant 1996; 18:1013-5.
104. Kumar RR, Kumar BR, Shafiulla M, Lakshmaiah KC, Sridhar H. Fusarium solani infection in a patient with acute myelogenous leukemia: a case report. Indian J Pathol Microbiol 1997; 40:555-7.
105. Vasiloudes P, Morelli JG, Weston WL. Painful skin papules caused by concomitant Acremonium and Fusarium infection in a neutropenic child. J Am Acad Dermatol 1997; 37:1006-8.
106. Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997; 112: 1128-30.
107. Baran R, Tosti A, Piraccini BM. Uncommon clinical patterns of Fusarium nail infection: report of three cases. Br J Dermatol 1997; 136: 424-7.
108. Fang CT, Chang SC, Tang IL, et al. Fusarium solani fungemia in a bone marrow transplant recipient. J Formos Med Assoc 1997; 96:129-33.
109. Krcmery V Jr, Jesenska Z, Spanik S, et al. Fungaemia due to Fusarium spp in cancer patients. J Hosp Infect 1997; 36:223-8.
110. Yildiran ST, Komurcu S, Saracli MA, et al. Fusarium fungaemia in severely neutropenic patients. Mycoses 1998; 41:467-9.
111. Game MA, Owen WC, Mitchell DK. Cutaneous manifestations of disseminated fungal infection in an immunocompromised child. J Pediatr 1998; 133:466.
112. Sander A, Beyer U, Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO). Mycoses 1998; 41:109-11.
113. Segal BH, Walsh TJ, Liu JM, Wilson JD, Kwon-Chung KJ. Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J Clin Microbiol 1998; 36:1772-6.
114. Guinvarc’h A, Guilbert L, Marmorat-Khuong A, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998; 41:59-61.
115. Antunes NL, Hariharan S, DeAngelis LM. Brain abscesses in children with cancer. Med Pediatr Oncol 1998; 31:19-21.
116. Paugam A, Baixench MT, Frank N, et al. Localized oral Fusarium infection in an AIDS patient with malignant lymphoma. J Infect 1999; 39:153-4.
117. Mangini C, de Camargo B. Fungal infection due to Fusarium (spp) in children with refractory hematologic malignancies. Med Pediatr Oncol 1999; 32:149-50.
118. Farina C, Vailati F, Manisco A, Goglio A. Fungaemia survey: a 10-year experience in Bergamo, Italy. Mycoses 1999; 42:543-8.
119. Ariffin H, Ariffin W, Mohamed M, Arasu A, Peng LH. Management of systemic Fusarium infection in children with leukemia. Med Pediatr Oncol 1999; 33:598-9.
120. Tacyildiz N, Yavuz G, Unal E, Gozdasoglu S, Ertem M, Aysev D. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies. Med Pediatr Oncol 1999; 33:596-7.
121. Girardi M, Glusac EJ, Imaeda S. Subcutaneous Fusarium foot abscess in a renal transplant patient. Cutis 1999; 63:267-70.
122. Girmenia C, Iori AP, Boecklin F, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica 1999; 84:114-8.
123. Peltroche-Llacsahuanga H, Manegold E, Kroll G, Haase G. Case report: pathohistological findings in a clinical case of disseminated infection with Fusarium oxysporum. Mycoses 2000; 43:367-72.
124. Fergie JE, Huang DB, Purcell K, Milligan T. Successful treatment of Fusarium solani ecthyma gangrenosum in a child with acute lymphoblastic leukemia in relapse. Pediatr Infect Dis J 2000; 19:579-81.
125. Lo NL, Di Cataldo A, Ragusa R. Successful treatment of Fusarium (spp) infection in a child with acute lymphoblastic leukemia. Med Pediatr Oncol 2000; 34:356-7.
126. Guarro J, Nucci M, Akiti T, Gene J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol 2000; 38:3460-2.
127. Musa MO, Al Eisa A, Halim M, et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol 2000; 108:544-8.
128. Okada H, Hamatani S, Kondo M, et al. Successful treatment of disseminated Fusarium infection in an infant with leukemia. Int J Hematol 2000; 72:494-8.
129. Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001; 32:1237-40.
130. Austen B, McCarthy H, Wilkins B, Smith A, Duncombe A. Fatal disseminated fusarium infection in acute lymphoblastic leukaemia in complete remission. J Clin Pathol 2001; 54:488-90.
131. Miyazaki M, Miyakoshi S, Kami M, et al. Systemic fusariosis after a preparative regimen including thiotepa, VP-16 and busulfan used for blood stem cell transplantation in Hodgkin’s disease. Leuk Lymphoma 2001; 40:441-4.
132. Anaissie EJ, Kuchar RT, Rex JH, et al. Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 2001; 33:1871-8.
133. Carrillo-Munoz AJ, Quindos G, Ruesga M, et al. Activity of itraconazole against clinical isolates of Aspergillus spp and Fusarium spp determined by the M38-P NCCLS method. Rev Esp Quimioter 2001; 14:281-5.
134. Romano C, Miracco C, Difonzo EM. Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy. Mycoses 1998; 41:433-7.
135. Resnik BI, Burdick AE. Improvement of eumycetoma with itraconazole. J Am Acad Dermatol 1995; 33:917-9.
136. Reis A, Sundmacher R, Tintelnot K, Agostini H, Jensen HE, Althaus C. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000; 84:932-3.
137. Clancy CJ, Nguyen MH. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur J Clin Microbiol Infect Dis 1998; 17:573-5.
138. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999; 37:3946-51.
139. Lozano-Chiu M, Arikan S, Paetznick VL, Anaissie EJ, Loebenberg D, Rex JH. Treatment of murine fusariosis with SCH 56592. Antimicrob Agents Chemother 1999; 43:589-91.